Jefferies Maintains a 'Buy' on Myriad Genetics (MYGN); Solid Q4 Supports FY13 Outlook
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $3.03 --0%
Rating Summary:
7 Buy, 19 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Rating Summary:
7 Buy, 19 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Join SI Premium – FREE
Jefferies maintains a 'Buy' on Myriad Genetics (NASDAQ: MYGN) price target of $31.00.
Analyst, Jon Wood, said, "MYGN's fiscal-4Q12 (Jun) EPS of $0.34 matched both our & the consensus views as modestly better revenue growth was offset by slightly higher expense trends. Our FY13 EPS forecast ($1.45 profit) and price target of $31 are unchanged."
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $25.47 yesterday.
Analyst, Jon Wood, said, "MYGN's fiscal-4Q12 (Jun) EPS of $0.34 matched both our & the consensus views as modestly better revenue growth was offset by slightly higher expense trends. Our FY13 EPS forecast ($1.45 profit) and price target of $31 are unchanged."
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $25.47 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson Following Q2 Results
- Seaport Global Securities Downgrades JetBlue Airways (JBLU) to Neutral
- Arthur J. Gallagher (AJG) PT Raised to $300 at Argus
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
